National Coverage Determination (NCD) 160.18 Vagus Nerve Stimulation (VNS)

MLN Matters Number: MM11461
Related CR Release Date: May 22, 2020
Related CR Transmittal Number: 10145NCD
Related Change Request (CR) Number: 11461
Effective Date: February 15, 2019
Implementation Date: June 23, 2020

CR 11461 notifies MACs that effective for claims with dates of service on or after February 15, 2019, the Centers for Medicare & Medicaid Services (CMS) will cover Food and Drug Administration (FDA) approved vagus nerve stimulation (VNS) devices for treatment resistant depression (TRD) through Coverage with Evidence Development (CED) for patients that meet specific conditions of coverage and criteria. Please make sure your billing staffs are aware of this change.

View the complete CMS Medicare Learning Network (MLN) Matters (MM)11461.


            Last Updated Thu, 25 Jun 2020 15:05:21 +0000